reference/17671192

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17671192

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	485
issn	1432-1335 0171-5216
issueIdentifier	2
pageRange	475-485
publicationName	Journal of Cancer Research and Clinical Oncology
startingPage	475
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c47ba281defab81903a17f7e7dafa4c3 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7661c63e9b96deee51af6f6e868602c2 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_20d59722499c12b6eb52b97c6a746454
bibliographicCitation	Öcal O, Schütte K, Kupčinskas J, Morkunas E, Jurkeviciute G, de Toni EN, Ben Khaled N, Berg T, Malfertheiner P, Klümpen HJ, Sengel C, Basu B, Valle JW, Benckert J, Gasbarrini A, Palmer D, Seidensticker R, Wildgruber M, Sangro B, Pech M, Ricke J, Seidensticker M. Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial. Journal of Cancer Research and Clinical Oncology. 2021 Apr 14;148(2):475–85. doi: 10.1007/s00432-021-03627-1.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8677c58138cc45df7d12a50030823548 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_818852f2e26733c6abdebfc2af2efd3c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eeb399194ec0b7464766b6be839cf063 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5234-1921 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e99d865819afe7b1fcaae21c6e85a0c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_860fc1688f057dfe06bd0ab373e188d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_03e13b4833783d355561bd24cbb9b460 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a9f97de9fbbdae252a64e2f12b6ebcd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82ebe16d13653186c7ab8f233e1fa8e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d71c96e12531564a1d7d5eba7867d4d7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f6e8fde0754c70a6c080ce9ba0929e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_179ddb98d70a83b26d29b190ab800478 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71f4c5506e9b50ca3df92d1754762c62 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a75bad9d7d154fa1e5c382dd18a9c8b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c605329150631cf2e47bbf2d56ad2fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3562-2868 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98e48d2508b7c33d6b8c157053eb4ac7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2481-5410 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a523c8224d58d6684a786bb9a425bc1b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a00dd6fe24f2b3fed001fbdb160a1122 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b3a4851bf703c721b201bbb3241897d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c27a94ad070c8f7254e93d2e5965ac76 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1285f75261e649a248c824ca3075c8aa
date	2021-04-14^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/33855585 https://doi.org/10.1007/s00432-021-03627-1 https://pubmed.ncbi.nlm.nih.gov/PMC8800931
isPartOf	https://portal.issn.org/resource/ISSN/1432-1335 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4574 https://portal.issn.org/resource/ISSN/0171-5216
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial
discusses	http://id.nlm.nih.gov/mesh/M0024750 http://id.nlm.nih.gov/mesh/M0446095 http://id.nlm.nih.gov/mesh/M0024272
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016209Q000097 http://id.nlm.nih.gov/mesh/D015850Q000097 http://id.nlm.nih.gov/mesh/D008113Q000188 http://id.nlm.nih.gov/mesh/D000077157Q000627 http://id.nlm.nih.gov/mesh/D006528Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D006528Q000175 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D008113Q000401 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008113Q000175 http://id.nlm.nih.gov/mesh/D008113Q000473 http://id.nlm.nih.gov/mesh/D005060Q000453 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D011237 http://id.nlm.nih.gov/mesh/D014421Q000453 http://id.nlm.nih.gov/mesh/D006528Q000401 http://id.nlm.nih.gov/mesh/D006528Q000473 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D005500
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d2a6d33ebbdffb2469b199f83c3ab1b1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1f89d53127fac03812c245bc89053817

Showing number of triples: 1 to 82 of 82.